Study identifier:D2287R00114
ClinicalTrials.gov identifier:NCT03131362
EudraCT identifier:N/A
CTIS identifier:N/A
REALizing and Improving Management of Stable COPD in China--A Multi-centre, Prospective, Observational Study to Realize the Current Situation of COPD Patients in China.
Chronic Obstructive Pulmonary Disease COPD
N/A
No
-
All
5020
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2022 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|